Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

KIOR Insider Trading

KIOR | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at KIOR provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2014-03-25 04:41 2014-03-21 Peterson Stuart L 10% owner SELL $0.70 182,900 $128,030 5,634,297 -3.1%
2014-03-21 01:54 2014-03-18 Peterson Stuart L 10% owner SELL $0.65 900,000 $585,000 5,817,197 -13.4%
2014-03-20 01:31 2014-03-17 Cannon Fred Director, Officer - President and CEO OPT+S $1.10 70,862 $78,246 606,997 0.0%
2014-03-20 01:25 2014-03-17 Kasbaum John Officer - Senior VP of Commercial OPT+S $1.10 13,792 $15,224 108,348 0.0%
2014-03-20 01:13 2014-03-17 Artzer Christopher A Officer - VP,General Counsel & Secretary OPT+S $1.10 18,203 $20,100 95,296 0.0%
2014-03-14 02:26 2014-03-11 Kasbaum John Officer - Senior VP of Commercial OPT+S $1.26 9,995 $12,587 84,491 0.0%
2014-03-14 02:01 2014-03-11 Cannon Fred Director, Officer - President and CEO OPT+S $1.26 29,332 $36,911 447,923 0.0%
2014-03-14 02:00 2014-03-11 Artzer Christopher A Officer - VP,General Counsel & Secretary OPT+S $1.26 9,823 $12,364 59,689 0.0%
2014-03-14 00:30 2014-03-11 Peterson Stuart L 10% owner SELL $1.27 76,282 $97,122 6,717,197 -1.1%
2014-03-11 00:16 2014-03-06 Cannon Fred Director, Officer - President and CEO SELL $1.52 10,218 $15,581 396,422 -2.5%
2014-03-07 02:38 2014-03-04 Peterson Stuart L 10% owner SELL $1.50 200,000 $300,000 6,793,479 -2.9%
2014-02-28 04:07 2014-02-25 Peterson Stuart L 10% owner SELL $1.35 203,574 $274,784 6,993,479 -2.8%
2014-02-20 03:14 2014-02-14 Peterson Stuart L 10% owner SELL $1.16 94,117 $108,827 7,368,617 -1.3%
2014-02-14 02:30 2014-02-11 Peterson Stuart L 10% owner SELL $1.17 150,000 $175,455 7,462,734 -2.0%
2014-01-24 04:47 2014-01-21 Peterson Stuart L 10% owner SELL $1.51 112,300 $169,449 7,612,734 -1.5%
2014-01-18 02:43 2014-01-15 Peterson Stuart L 10% owner SELL $1.40 100,000 $139,790 7,725,034 -1.3%
2014-01-11 03:53 2014-01-08 Peterson Stuart L 10% owner SELL $1.76 20,154 $35,471 7,825,034 -0.3%
2014-01-08 04:03 2014-01-03 Peterson Stuart L 10% owner SELL $1.70 167,047 $283,145 7,845,188 -2.1%
2014-01-04 00:46 2013-12-31 Peterson Stuart L 10% owner SELL $1.71 39,200 $66,856 8,012,235 -0.5%
2014-01-01 02:30 2013-12-27 Peterson Stuart L 10% owner SELL $1.74 45,000 $78,300 9,051,435 -0.5%
2013-12-28 05:42 2013-12-24 Peterson Stuart L 10% owner SELL $1.54 81,949 $125,947 9,096,435 -0.9%
2013-12-28 05:34 2013-12-24 Artis Partners 2X Ltd 10% owner SELL $1.54 81,949 $125,947 2,248,680 -3.5%
2013-12-25 00:03 2013-12-20 Peterson Stuart L 10% owner SELL $1.59 350,000 $556,500 9,178,384 -3.7%
2013-12-25 00:10 2013-12-20 Artis Partners 2X Ltd 10% owner SELL $1.59 174,437 $277,355 2,330,629 -7.0%
2013-10-02 23:25 2013-09-10 BIOeCON B.V. 10% owner SELL $2.45 150,000 $367,560 2,135,000 -6.6%
2013-09-10 23:10 2013-09-05 BIOeCON B.V. 10% owner SELL $1.48 150,000 $222,495 2,285,000 -6.2%
2013-09-07 02:16 2013-09-04 Cannon Fred Director, Officer - President and CEO SELL $1.93 15,672 $30,266 406,640 -3.7%
2013-09-07 02:17 2013-09-04 KARNES JOHN H JR Officer - Chief Financial Officer SELL $1.93 2,053 $3,967 109,546 -1.8%
2013-08-15 23:47 2013-08-15 WHITLOCK GARY L Director BUY $2.73 5,000 $13,650 34,358 +17.0%
2013-06-27 19:53 2013-06-25 Kasbaum John Officer - Senior VP of Commercial SELL $4.55 1,251 $5,695 69,539 -1.8%
2013-06-10 23:42 2013-06-06 BIOeCON B.V. 10% owner SELL $4.11 11,176 $45,933 935,000 -1.2%
2013-05-08 17:46 2013-05-07 Kasbaum John Officer - Senior VP of Commercial SELL $4.88 10,094 $49,259 70,790 -12.5%
2013-05-08 17:42 2013-05-07 Cannon Fred Director, Officer - President and CEO SELL $4.88 37,082 $180,960 422,312 -8.1%
2013-05-08 17:40 2013-05-07 Artzer Christopher A Officer - VP,General Counsel & Secretary SELL $4.88 9,802 $47,834 44,995 -17.9%
2013-05-08 17:44 2013-05-07 KARNES JOHN H JR Officer - Chief Financial Officer SELL $4.88 13,517 $65,963 111,599 -10.8%
2013-03-28 00:15 2013-03-27 WHITLOCK GARY L Director BUY $4.77 5,000 $23,830 29,358 +20.5%
2013-03-20 00:02 2013-03-15 BIOeCON B.V. 10% owner SELL $6.08 23,824 $144,736 946,176 -2.5%
2013-03-15 23:33 2013-03-13 BIOeCON B.V. 10% owner SELL $6.02 30,000 $180,450 970,000 -3.0%
2013-03-14 23:43 2013-03-12 Artzer Christopher A Officer - VP,General Counsel & Secretary OPT+S $5.82 7,708 $44,861 22,226 0.0%
2013-03-14 23:42 2013-03-04 Cannon Fred Director, Officer - President and CEO OPT+S $5.70 32,296 $184,119 351,966 0.0%
2013-03-14 23:40 2013-03-12 Kasbaum John Officer - Senior VP of Commercial OPT+S $5.82 7,866 $45,780 47,741 0.0%
2013-03-14 23:40 2013-03-12 Lyle W. Roger Officer - SVP of Operations OPT+S $5.77 9,246 $53,349 42,098 0.0%
2013-03-14 23:40 2013-03-04 KARNES JOHN H JR Officer - Chief Financial Officer OPT+S $5.72 12,186 $69,650 79,402 0.0%
2013-02-02 00:36 2013-01-14 O'Connor Paul 10% owner SELL $6.26 80,000 $501,000 2,378,421 -3.3%
2013-01-16 04:40 2013-01-04 O'Connor Paul 10% owner SELL $6.79 60,000 $407,502 1,458,421 -4.0%
2013-01-07 15:24 2012-12-17 O'Connor Paul 10% owner SELL $6.26 130,000 $814,294 1,518,421 -7.9%
2012-12-21 00:10 2012-12-07 O'Connor Paul 10% owner SELL $6.00 70,000 $419,902 1,648,421 -4.1%
2012-12-12 01:05 2012-11-29 O'Connor Paul 10% owner SELL $6.04 50,000 $301,900 1,718,421 -2.8%
2012-12-01 00:24 2012-11-21 O'Connor Paul 10% owner SELL $6.11 50,000 $305,500 1,768,421 -2.7%
2012-11-23 15:31 2012-11-14 O'Connor Paul 10% owner SELL $6.30 50,000 $315,100 1,818,421 -2.7%
SHOW ENTRIES

How to Interpret $KIOR Trades

Not every insider transaction in KIOR is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $KIOR shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for KIOR

Insider activity data for KIOR is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $KIOR, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.